Recently, the Women and Equalities Committee (WEC) published its report on cosmetic procedures, a document that could signal a turning point for women’s health in the UK.
Dr Farr provided written evidence which focussed on the need for better data, long-term health monitoring, and the systematic analysis of implants after removal (explant analysis).
The report makes several important recommendations, including:
- A call for mandatory recording of breast implant and explant procedures by the end of 2026.
- A recommendation for research to better understand the health impacts of breast implants, including potential effects on women with pre-existing autoimmune conditions.
- A clear statement that “at present, we do not believe that enough information is available about breast implants for women to genuinely be able to give informed consent”.
- A recommendation that primary care workers be made aware of potential links between autoimmune conditions and breast implants so that women presenting with symptoms are not dismissed.
Much of Dr Farr’s research was done outside of traditional funded hours, driven by a commitment to patient safety and the belief that surgical devices require the same level of rigorous, independent analysis as orthopaedic implants.
Dr Farr said: “Recognition by a parliamentary committee is very welcome. I sincerely hope that this report marks a turning point and that the need for rigorous, independent, and adequately funded research in this area is finally acknowledged.”
Dr Farr has been invited to return to Parliament in May to address the Women and Equalities Committee again, where he will provide further expert testimony on explant analysis, transparency, and current liability frameworks.